Validation of a Mass Spectrometry–Based Proteomics Molecular Pathology Assay
Molecular & Cellular Proteomics · 2026-01 · 25 (1) · 101487
DOI: 10.1016/j.mcpro.2025.101487 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Molecular & Cellular Proteomics, 2026-01. Verfasst von Jessica R Chapman und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. Electronic address: chapmanj@mskcc.org. Hauptthemen laut MEDLINE: Proteomics, Mass Spectrometry, Pathology, Molecular. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Farmer Family Foundation, National Institutes of Health.
Abstract (Originalsprache)
Mass spectrometry-based proteomics has been applied to many fields and has made major contributions to our understanding of biology and medicine. Translation of this technology and assays to patient testing has been limited despite grand expectations. The amyloid protein identification by LC-MS test is one successful example of the adaptation of this technology by molecular and clinical pathology laboratories. Through the illustration of this assay, we will address some of these challenges and outline a process for validation and implementation of mass spectrometry-based proteomics in the molecular pathology laboratory.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. Electronic address: chapmanj@mskcc.org.
- Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
Förderung
- NCI NIH HHS
- Farmer Family Foundation
- National Institutes of Health
Zitieren
APA
Chapman, J. R., Baik, J., Mereuta, O. M., Yi, S., Walland, A. C., Flor, K., Wooten, A., Wardrope, J., Ritorto, M. S., & Dogan, A. (2026). Validation of a Mass Spectrometry–Based Proteomics Molecular Pathology Assay. Molecular & Cellular Proteomics, 25(1), 101487. https://doi.org/10.1016/j.mcpro.2025.101487
Vancouver
Chapman JR, Baik J, Mereuta OM, Yi S, Walland AC, Flor K, et al. Validation of a Mass Spectrometry–Based Proteomics Molecular Pathology Assay. Molecular & Cellular Proteomics. 2026;25(1):101487. doi:10.1016/j.mcpro.2025.101487
BibTeX
@article{Chapman2026,
author = {Chapman, Jessica R and Baik, Jeeyeon and Mereuta, Oana Madalina and Yi, Sansan and Walland, Ayal Cooper and Flor, Kristel and Wooten, Ashley and Wardrope, Jessica and Ritorto, Maria Stella and Dogan, Ahmet},
title = {Validation of a Mass Spectrometry–Based Proteomics Molecular Pathology Assay},
journal = {Molecular & Cellular Proteomics},
year = {2026},
volume = {25},
number = {1},
pages = {101487},
doi = {10.1016/j.mcpro.2025.101487}
}
EUVIMED